Filing Details

Accession Number:
0001209191-22-043510
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-29 16:18:14
Reporting Period:
2022-07-27
Accepted Time:
2022-07-29 16:18:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595893 Turning Point Therapeutics Inc. TPTX Pharmaceutical Preparations (2834) 463826166
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1707648 Paolo Tombesi 10628 Science Center Drive
San Diego CA 92121
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-07-27 1,183 $74.94 28,700 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on July 26, 2021.